Skip to main content
Log in

Identification of the Major Components of Resina Draconis Extract and Their Metabolites in Rat Urine by LC-ESI-MSn

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

The aim of our study was to employ a liquid chromatography coupled with electrospray ionization multistage tandem mass spectrometry (LC-ESI-MSn) method for the identification of the major components of Resina Draconis extract (RDE) and their metabolites in rat urine. Based on the above, 18 compounds were tentatively identified from the RDE. Among them, 4 compounds were unambiguously characterized by the comparison of the retention time and mass spectra with those of reference compounds and 14 compounds were tentatively identified by comparing the mass spectra with those of literature. In vivo, 21 compounds, including 13 parent compounds and 8 metabolites, were detected in rat urine after oral administration of RDE. The results may be helpful for future research on traditional Chinese medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Zheng QG, Chen JT, Zhang YJ, Yang CR (2005) The chemical constituents and pharmaceutical activities of Dragon’s blood, a famous traditional medicinal herb. Nat Prod Res Dev 17(Suppl):84–95

    Google Scholar 

  2. Choy C, Hu C, Chiu W, Wang T (2008) Suppression of lipopolysaccharide-induced of inducible nitric oxide synthase and cyclooxy -genase-2 by Sanguis Draconis, a dragon’s blood resin, in RAW 264.7 cells. J Ethnopharmacol 115:455–462

    Article  CAS  Google Scholar 

  3. Deepika G, Bruce B, Rajinder KG (2008) Dragon’s blood: botany, chemistry and therapeutic uses. J Ethnopharmacol 115:361–380

    Article  Google Scholar 

  4. Paul B, Masih I, Deopujari J, Charpentier C (1999) Occurrence of resveratrol and pterostilbene in age-old darakchasava, an ayurvedic medicine from India. J Ethnopharmacol 68:71–76

    Article  CAS  Google Scholar 

  5. Cichocki M, Paluszczak J, Szaefer H, Piechowiak A, Rimando AM, Baer-Dubowska W (2008) Pterostilbene is equally potent as resveratrol in inhibiting 12-O-tetradecanoylphorbol-13-acetate activated NFkB, AP-1, COX-2, and iNO S in mouse epidermis. Mol Nutr Food Res 52(Suppl. 1):S62–S70

    Google Scholar 

  6. Frankel EN, Waterhouse AL, Kinsella JE (1993) Inhibition of human LDL oxidation by resveratrol. Lancet 341:1103–1104

    Article  CAS  Google Scholar 

  7. Zhang YS, Li YZ, Chen B, Deng YL, Li YJ (2011) Simultaneous quantification of loureirin A and loureirin B in rat urine, feces, and bile by HPLC-MS/MS method and its application to excretion study. Anal Bioanal Chem 400:1181–1187

    Article  CAS  Google Scholar 

  8. Fan LL, Tu PF, Chen HB, Cai SQ (2009) Simultaneous quantification of five major constituents in stems of Dracaena plants and related medicinal preparations from China and Vietnam by HPLC-DAD. Biomed Chromatogr 23:1191–1200

    Article  CAS  Google Scholar 

  9. Chen X, Yong K, Lv JC, Zhang TB (2009) Analysis on migrating constituents absorbed into blood of mice after i.g. administration of Resina Draconis. Zhongcaoyao 40:352–355

    Google Scholar 

  10. Wang DG, Hang TJ, Wu CY, Liu WY (2005) Identification of the major metabolites of resveratrol in rat urine by HPLC-MS/MS. J Chromatogr B 829:97–106

    Article  CAS  Google Scholar 

  11. Shao X, Chen XX, Badmaev V, Ho CT, Sang SM (2010) Structural identification of mouse urinary metabolites of pterostillbene using liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 24:1770–1778

    Article  CAS  Google Scholar 

  12. Fabio M, Leonardo DD, Hicham B, Bartolo G, Anna N, Giovanni S (2010) The assay of pterostilbene in spiked matrices by liquid chromatography tandem mass spectrometry and isotope dilution method. J Mass Spectrom 45:358–363

    Google Scholar 

  13. Wei H, Wen DX, Liu XS, Tang RJ (1998) Constituents in petroleum ether and ethyl acetate extract fractions of Dracaena cochinensis (Lour.) S.C.Chen. China J Chin Mater Med 23:616–619

    CAS  Google Scholar 

  14. Lu WJ, Wang X, Chen J, Lu Y, Wu N, Kang W, Zheng Q (1998) Studies on the chemical constituents of chloroform extract of Dracaena cochinchinensis. Acta Pharm Sinica 33:755–758

    CAS  Google Scholar 

  15. Zhou ZH, Wang JL, Yang ZR (2001) Cochinchinenin-a new chalcone dimer from the Chinese dragon blood. Acta Pharm Sinica 36:200–204

    CAS  Google Scholar 

  16. Duangdeun M, Geoffrey AC (1988) Retrodihydrochalcones from Dracaena Loureiri. J Nat Prod 51:1129–1135

    Article  Google Scholar 

  17. Zhou ZH, Wang JL, Yang ZR (2001) Chemical constituents of Sanguis Draxonis made in China. Zhongcaoyao 32:484–486

    CAS  Google Scholar 

  18. Tu PF, Tao J, Hu YQ, Zhao MB (2003) Flavones from the Wood Dracaena cochinchinensis. Zhongguo Tianran Yaowu 1:27–29

    CAS  Google Scholar 

  19. Zheng QA, Li HZ, Zhang YJ, Yang CR (2004) Flavonoids from the Resin of Dracaena cochinchinensis. Helv Chim Acta 87:1167–1171

    Article  CAS  Google Scholar 

  20. Zhu YD, Zhang P, Yu Haiping, Li J (2007) Anti-Helicobacter pylori and Thrombin Inhibitory Components from Chinese Dragon’s Blood, Dracaena cochinchinensis. J Nat Prod 70:1570–1577

    Article  CAS  Google Scholar 

  21. Wang JL, Li XC, Jiang DF, Ma P, Yang ZR (1995) Chemical constituents of Dragon’s Blood Resin from Dracaena cochinchinensis in Yunnan and their antifungal activity. Yunnan Zhiwu Yanjiu 17:336–340

    CAS  Google Scholar 

  22. He L, Wang ZH, Li HM, He LX (2003) Chemical constituents from resin of Dracaena cochinchinensis (II). China J Chin Mater Med 28:1195

    CAS  Google Scholar 

  23. Zhou ZH, Wang JL, Yang ZR (1999) Three Glycosides from the Chinese Dragon’s Blood (Dracaena cochinchinensis). Zhongcaoyao 30:801–804

    CAS  Google Scholar 

  24. Qiao X, Han J, Xu M, Zhang ZC, Ye M, Ye G, Guo DA (2011) Metabolic profiling of GuanXin II prescription based on metabolic fingerprinting and chemical analysis. J Pharm Biomed Anal 54:789–798

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The subject was supported by the National Science and Technology Major Project “Key New Drug Creation and Manufacturing Program”, China (nos. 2012ZX09301001-001 and 2011ZX09201-201-20).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jun Yin or Chenggang Huang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, F., Wu, B., Xiao, W. et al. Identification of the Major Components of Resina Draconis Extract and Their Metabolites in Rat Urine by LC-ESI-MSn . Chromatographia 76, 1131–1139 (2013). https://doi.org/10.1007/s10337-013-2473-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-013-2473-z

Keywords

Navigation